As of December 2024 Blueprint Medicines has a market cap of $6.12 Billion USD. This makes Blueprint Medicines the world's 2411th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 17th, 2024 the market cap of Blueprint Medicines was reported to be: